CANNABIS STRATEGIC VENTURES ESTABLISHES PARTNERSHIP WITH FELDMANN NAGEL CANTAFIO MARGULIS, PLLC FOR CANNABIS COMPLIANCE MATTERS
Los Angeles, CA -- November 29, 2018 -- InvestorsHub NewsWire -- Cannabis Strategic Ventures, Inc. (OTC: NUGS) announced a partnership with Feldmann Nagel Cantafio Margulis, PLLC a boutique lawfirm formed in early 2004 by Charles Feldmann and David Nagel, with deep cannabis compliance expertise throughout the United States, Israel, and the international cannabis marketplace. As an extension of the Cannabis Strategic Ventures Team, Charles E. Feldmann, Founding Partner, will lead the legal team on matters related to cannabis enforcement, licensing, federal risk mitigation and compliance related issues at the local, state, national and international level.
Attorney Charles Feldmann was a former federal prosecutor and defense attorney in the United States Marine Corps and a former states narcotics prosecutor in Colorado. He previously served as a Drug Enforcement Agency (DEA) Drug Task Force Commander and is a former lecturer and instructor with the Department of Defense and with the National College of District Attorneys. Feldmann oversees the firm’s international cannabis practice and its military justice international division.
“Cannabis Strategic Ventures is proud to partner with Charles Feldmann and the Feldmann Nagel Cantafio Margulis team for all cannabis compliance related to cultivation, distribution, retail matters for our brands,” said Simon Yu, CEO, Cannabis Strategic Ventures. “The ever-evolving regulatory landscape at the state and national levels, and the increasing number of countries implementing cannabis-friendly legislations, makes it became critically important to have reputable experts on cannabis enforcement, licensing, federal risk mitigation on our team.”
Charles Feldmann stated “Our law firm looks forward to being a strategic advisor and counselor to Cannabis Strategic Ventures, a publicly traded cannabis corporation, and providing their exceptional team with diverse legal and business expertise.”
Cannabis Strategic Ventures is committed to building category leaders within the cannabis and CBD space. A recent Grandview Research Report states that the global legal marijuana market is expected to reach USD 146.4 billion by the end of 2025 as legal marijuana continues to gain traction worldwide due to very high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. This week, South Korea legalized medical cannabis, laying the foundation for reform in Southeast Asia.
About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publically traded on the U.S. Over the Counter Market with the stock symbol NUGS.
About Feldmann Nagel Cantafio Margulis, PLLC
Feldmann Nagel Cantafio Margulis has a reputation for achieving exceptional results for clients in a variety of practices around the world. The firm was formed in early 2004 by Charles Feldmann and David Nagel. Charles Feldmann's roots stem from his training as a JAG prosecutor and defense attorney with the United States Marine Corps and then his transition into state and federal governmental practice as a drug task force commander with the DEA and a local state deputy district attorney. The firm’s attorneys are committed to providing exceptional legal services to their clients and have earned distinctions from a number of professional organizations, including Martindale-Hubbell® and Super Lawyers® Magazine.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.